Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study. — ME/CFS Atlas
E2 ModeratePreliminaryPEM not requiredCross-SectionalPeer-reviewedReviewed
Standard · 3 min
Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study.
Kristiansen, Miriam Skjerven, Stabursvik, Julie, O'Leary, Elise Catriona et al. · Brain, behavior, and immunity · 2019 · DOI
Quick Summary
This study looked at adolescents who had Epstein-Barr virus (EBV) infection and tracked whether they developed chronic fatigue 6 months later. Researchers found that those with ongoing fatigue had more symptoms overall, but blood tests and heart-monitoring showed only small differences compared to those who recovered—mainly slightly higher inflammation markers and changes in nervous system activity. The study suggests that post-EBV fatigue in teenagers involves subtle changes in the body's stress and immune systems, even though the virus itself had cleared.
Why It Matters
This study is one of few to systematically characterize biological mechanisms in post-viral ME/CFS in an adolescent population, a group in whom post-EBV fatigue is common but understudied. It provides evidence that chronic fatigue following EBV involves real physiological alterations in immune and autonomic function, not solely psychogenic mechanisms, validating patient experiences while highlighting the need for more mechanistic research to guide treatment.
Observed Findings
Fatigued adolescents showed significantly higher symptom scores across all domains measured.
Plasma norepinephrine and epinephrine were slightly elevated in the fatigued group (1420 vs 1113 pmol/L and 363 vs 237 nmol/L, respectively).
Heart rate variability analysis revealed attenuated parasympathetic responsiveness during controlled breathing in the fatigued group (LF/HF decline -0.11 vs -0.25).
Serum C-reactive protein was marginally higher in the fatigued group (0.48 vs 0.43 mg/L).
Total T-cell (CD3+) counts were slightly elevated in the fatigued group (median 1573 vs 1481 × 10⁶ cells/L).
Inferred Conclusions
Post-EBV chronic fatigue in adolescents is associated with subtle autonomic dysregulation characterized by sympathetic predominance relative to parasympathetic tone.
Inflammatory and neuroendocrine alterations are present but modest and do not strongly correlate with symptom severity, suggesting fatigue symptoms may be driven by mechanisms not captured by these traditional biomarkers.
The absence of elevated viral load in fatigued versus non-fatigued groups indicates persistent symptoms are not due to ongoing active viral replication.
Remaining Questions
What mechanisms drive the symptoms in fatigued adolescents when traditional immune and autonomic markers show minimal abnormality?
What This Study Does Not Prove
This study does not prove that subtle immune or autonomic changes cause chronic fatigue symptoms—the weak symptom-biomarker correlations suggest other mechanisms may be more important. The cross-sectional design cannot establish causality or temporal relationships. The findings also do not identify a single diagnostic biomarker for post-EBV fatigue, as individual markers have modest effect sizes and overlap significantly between fatigued and non-fatigued groups.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.